(Circulation. 1995;92:1193-1202.)
© 1995 American Heart Association, Inc.
Articles |
Dynamic Electrophysiological Behavior of Human Atria During Paroxysmal Atrial Fibrillation
From the Institute of Cardiovascular Diseases, University of Bologna (Italy) and the Medical Biophysics Area, C.M.B.M., Trento, Italy (F.R., G.N.).
Correspondence to Mauro Biffi, MD, Institute of Cardiovascular Diseases, University of Bologna, Via Massarenti 9, 40138 Bologna, Italy.
Background The aims of our study were to investigate the meaning of local atrial activation and its behavior during paroxysmal atrial fibrillation and to study the effect of overdrive pacing on local atrial activity.
Methods and Results Twenty-five patients with lone paroxysmal atrial fibrillation underwent electrophysiological study. Functional and effective atrial refractoriness was determined. Mean and fifth percentile values of 100 consecutive atrial fibrillation intervals (FF) were evaluated at three atrial sites either at arrhythmia onset or at self-termination (or at minute 5). A high-voltage burst pacing was performed after 6 minutes of stable atrial fibrillation in 10 patients. Mean FF intervals were evaluated 5 seconds before and after atrial pacing. Forty-nine atrial fibrillation episodes were induced: 39 self-terminating within 5 minutes and 10 long-lasting. A significant correlation was found between mean FF and atrial functional refractory period (r=.73, P<.001) and between fifth percentile FF and atrial effective refractory period (r=.57, P<.005). Atrial fibrillation self-termination was associated with significant mean FF prolongation, whereas long-lasting fibrillation behaved the opposite. In 10 patients, burst pacing resulted in significant shortening of the mean FF at the stimulation site; no changes were observed in the two distant recording sites.
Conclusions The analysis of the FF intervals demonstrates a strict correlation with atrial functional refractoriness. The self-termination of atrial fibrillation is related to a prolongation of the functional refractoriness (mean FF), whereas a shortening of both functional and effective refractoriness (fifth percentile) is associated with atrial fibrillation persistence. The provoked shortening of the mean FF at the stimulation site is consistent with the presence of a gap of excitability during atrial fibrillation in the human atria.
Key Words: atrial fibrillation • electrophysiology • reentry
This article has been cited by other articles:
 |
|
 |
|
  A. Bollmann, D. Husser, A. Lindgren, M. Stridh, B. M. Hardig, C. Piorkowski, A. Arya, L. Sornmo, and S. B. Olsson Atrial fibrillatory rate and risk of stroke in atrial fibrillation Europace, May 1, 2009; 11(5): 582 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Husser, M. Stridh, L. Sornmo, D. M. Roden, D. Darbar, and A. Bollmann A Genotype-Dependent Intermediate ECG Phenotype in Patients With Persistent Lone Atrial Fibrillation: Genotype ECG-Phenotype Correlation in Atrial Fibrillation Circ Arrhythmia Electrophysiol, February 1, 2009; 2(1): 24 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bollmann, A. Tveit, D. Husser, M. Stridh, L. Sornmo, P. Smith, and S. B. Olsson Fibrillatory rate response to candesartan in persistent atrial fibrillation Europace, October 1, 2008; 10(10): 1138 - 1144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Husser, D. S. Cannom, A. K. Bhandari, M. Stridh, L. Sornmo, S. B. Olsson, and A. Bollmann Electrocardiographic characteristics of fibrillatory waves in new-onset atrial fibrillation Europace, August 1, 2007; 9(8): 638 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Husser, D. Husser, M. Stridh, L. Sornmo, V. D.A. Corino, L. T. Mainardi, F. Lombardi, H. U. Klein, S. B. Olsson, and A. Bollmann Exercise testing for non-invasive assessment of atrial electrophysiological properties in patients with persistent atrial fibrillation Europace, August 1, 2007; 9(8): 627 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bollmann, D. Husser, M. Stridh, F. Holmqvist, A. Roijer, C. J. Meurling, L. Sornmo, and S. B. Olsson Atrial fibrillatory rate and risk of left atrial thrombus in atrial fibrillation Europace, August 1, 2007; 9(8): 621 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Petrutiu, A. V. Sahakian, and S. Swiryn Abrupt changes in fibrillatory wave characteristics at the termination of paroxysmal atrial fibrillation in humans Europace, July 1, 2007; 9(7): 466 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bollmann, D. Husser, L. Mainardi, F. Lombardi, P. Langley, A. Murray, J. J. Rieta, J. Millet, S. B. Olsson, M. Stridh, et al. Analysis of surface electrocardiograms in atrial fibrillation: techniques, research, and clinical applications. Europace, November 1, 2006; 8(11): 911 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Holmqvist, M. Stridh, J. E. P. Waktare, J. Brandt, L. Sornmo, A. Roijer, and C. J. Meurling Rapid fluctuations in atrial fibrillatory electrophysiology detected during controlled respiration Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H754 - H760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Hassan, H. Oral, C. Scharf, A. Chugh, F. Pelosi, B. P. Knight, S. A. Strickberger, and F. Morady Rate-dependent effect of verapamil on atrial refractoriness J. Am. Coll. Cardiol., February 5, 2003; 41(3): 446 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sticherling, H. Tada, W. Hsu, A. C. Bares, H. Oral, F. Pelosi, B. P. Knight, S. A. Strickberger, and F. Morady Effects of Diltiazem and Esmolol on Cycle Length and Spontaneous Conversion of Atrial Fibrillation Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2002; 7(2): 81 - 88. [Abstract] [PDF]
|
|
|
|
 |
|
 M Biffi, G Boriani, M Bartolotti, L Bacchi Reggiani, R Zannoli, and A Branzi Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters Heart, May 1, 2002; 87(5): 443 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ricci, C. Pignalberil, M. Disertori, A. Capucci, L. Padeletti, G. Botto, G. Boriani, F. Miraglia, T. de Santo, and M. Santini Antitachycardia pacing therapy to treat spontaneous atrial tachyarrhythmias: the 7250 dual defibrillator Italian Registry Eur. Heart J. Suppl., November 1, 2001; 3(suppl_P): P25 - P32. [Abstract] [PDF]
|
|
|
|
 |
|
 S.P Fynn, D.M Todd, W.J.C Hobbs, K.L Armstrong, and C.J Garratt Role of dispersion of atrial refractoriness in the recurrence of clinical atrial fibrillation. A manifestation of atrial electrical remodelling in humans? Eur. Heart J., October 1, 2001; 22(19): 1822 - 1834. [Abstract] [PDF]
|
|
|
|
|
|
H. Ramanna, A. Elvan, F. H. M. Wittkampf, J. M. T. de Bakker, R. N. W. Hauer, and E. O. Robles de Medina Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1403 - 1407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gaita, L. Calo, R. Riccardi, L. Garberoglio, M. Scaglione, G. Licciardello, L. Coda, P. Di Donna, M. Bocchiardo, D. Caponi, et al. Different patterns of atrial activation in idiopathic atrial fibrillation: simultaneous multisite atrial mapping in patients with paroxysmal and chronic atrial fibrillation J. Am. Coll. Cardiol., February 1, 2001; 37(2): 534 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Platonov, S. Yuan, E. Hertervig, O. Kongstad, A. Roijer, A. B. Vygovsky, L. V. Chireikin, and S. B. Olsson Further evidence of localized posterior interatrial conduction delay in lone paroxysmal atrial fibrillation Europace, January 1, 2001; 3(2): 100 - 107. [Abstract] [PDF]
|
|
|
|
|
|
L.-P. Lai, J.-L. Lin, W.-P. Lien, Y.-Z. Tseng, and S. K. S. Huang Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: assessment of the electrophysiological effects by biatrial basket electrodes J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1434 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. C. Hobbs, S. Fynn, D. M. Todd, P. Wolfson, M. Galloway, and C. J. Garratt Reversal of Atrial Electrical Remodeling After Cardioversion of Persistent Atrial Fibrillation in Humans Circulation, March 14, 2000; 101(10): 1145 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ramanna, R. N. W. Hauer, F. H. M. Wittkampf, J. M. T. de Bakker, E. F. D. Wever, A. Elvan, and E. O. Robles de Medina Identification of the Substrate of Atrial Vulnerability in Patients With Idiopathic Atrial Fibrillation Circulation, March 7, 2000; 101(9): 995 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shinagawa, H. Mitamura, A. Takeshita, T. Sato, H. Kanki, S. Takatsuki, and S. Ogawa Determination of refractory periods and conduction velocity during atrial fibrillation using atrial capture in dogs: Direct assessment of the wavelength and its modulation by a sodium channel blocker, pilsicainide J. Am. Coll. Cardiol., January 1, 2000; 35(1): 246 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.P. Ingemansson, B. Smideberg, and S.B. Olsson Intravenous MgSO4alone and in combination with glucose, insulin and potassium (GIK) prolong the atrial cycle length in chronic atrial fibrillation Europace, January 1, 2000; 2(2): 106 - 114. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Bollmann, K. Sonne, H.-D. Esperer, I. Toepffer, J. J Langberg, and H. U Klein Non-invasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG Cardiovasc Res, October 1, 1999; 44(1): 60 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Biffi, G Boriani, G Bronzetti, A Capucci, A Branzi, and B Magnani Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination Heart, August 1, 1999; 82(2): 176 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ohkusa, T. Ueyama, J. Yamada, M. Yano, Y. Fujumura, K. Esato, and M. Matsuzaki Alterations in cardiac sarcoplasmic reticulum Ca2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation J. Am. Coll. Cardiol., July 1, 1999; 34(1): 255 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Boriani, M. Biffi, A. Capucci, G. Bronzetti, G. M. Ayers, R. Zannoli, A. Branzi, and B. Magnani Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation J. Am. Coll. Cardiol., February 1, 1999; 33(2): 333 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.J. Meurling, M.P. Ingemansson, A. Roijer, J. Carlson, C.J. Lindholm, B. Smideberg, L. Sorno, M. Stridh, and S.B. Olsson Attenuation of electrical remodelling in chronic atrial fibrillation following oral treatment with verapamil Europace, January 1, 1999; 1(4): 234 - 241. [Abstract] [PDF]
|
|
|
|
|
|
M. Holm, R. Johansson, B. Smideberg, C. Luhrs, and S.B. Olsson Effect of cardiac exposure by median sternotomy on atrial fibrillation cycle length Europace, January 1, 1999; 1(4): 248 - 257. [Abstract] [PDF]
|
|
|
|
|
|
M P Ingemansson, M Holm, and S B Olsson Autonomic modulation of the atrial cycle length by the head up tilt test: non-invasive evaluation in patients with chronic atrial fibrillation Heart, July 1, 1998; 80(1): 71 - 76. [Abstract] [Full Text]
|
|
|
|
|
|
M. Holm, S. Pehrson, M. Ingemansson, L. Sornmo, R. Johansson, L. Sandhall, M. Sunemark, B. Smideberg, C. Olsson, and S.B. Olsson Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: introducing, validating and illustrating a new ECG method Cardiovasc Res, April 1, 1998; 38(1): 69 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ravelli and M. Allessie Effects of Atrial Dilatation on Refractory Period and Vulnerability to Atrial Fibrillation in the Isolated Langendorff-Perfused Rabbit Heart Circulation, September 2, 1997; 96(5): 1686 - 1695. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. R. Van Wagoner, A. L. Pond, P. M. McCarthy, J. S. Trimmer, and J. M. Nerbonne Outward K+ Current Densities and Kv1.5 Expression Are Reduced in Chronic Human Atrial Fibrillation Circ. Res., June 19, 1997; 80(6): 772 - 781. [Abstract] [Full Text]
|
|
|
|
|
|
D. Gallik, J. Altamirano, and B. N. Singh Review : Restoring Sinus Rhythm in Patients with Atrial Flutter and Fibrillation: Pharmacologic or Electrical Cardioversion? Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(2): 135 - 144. [Abstract] [PDF]
|
|
|
|
|
|
H. S. Friedman, B. Sinha, A. Tun, R. Pasha, A. Sharafkhaneh, and A. Bharadwaj Zones of Atrial Vulnerability: Relationships to Basic Cycle Length Circulation, September 15, 1996; 94(6): 1456 - 1464. [Abstract] [Full Text]
|
|
|
|
|
|
E. G. Daoud, B. Pariseau, M. Niebauer, F. Bogun, R. Goyal, M. Harvey, K. C. Man, S. A. Strickberger, and F. Morady Response of Type I Atrial Fibrillation to Atrial Pacing in Humans Circulation, September 1, 1996; 94(5): 1036 - 1040. [Abstract] [Full Text]
|
|